Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0302629 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jameela A Al Ajmi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar. Hauptthemen laut MEDLINE: Hospital Mortality. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
We investigated the spectrum of infection and risk factors for invasive fungal disease due to Candida auris (CA) in Qatar.
Methods
We performed structured chart reviews on individuals with any positive CA culture between May 2019 and December 2022 at three tertiary care hospitals in Qatar. Invasive CA disease (ICAD) was defined as a positive sterile site culture, or any positive culture for CA with appropriate antifungal prescription. Main outcomes included proportion of individuals who developed ICAD among those with positive cultures, and 30-day/in-hospital mortality.
Results
Among 331 eligible individuals, median age was 56 years, 83.1% were male, 70.7% were non-Qataris, and 37.5% had ≥ 3 comorbidities at baseline. Overall, 86.4% were deemed to have colonization and 13.6% developed ICAD. Those with ICAD were more likely to have invasive central venous or urinary catheterization and mechanical ventilation. Individuals with ICAD had longer prior ICU stay (16 vs 26 days, P = 0 . 002 ), and longer hospital length of stay (63 vs. 43 days; P = 0 . 003 ), and higher 30-day mortality (38% vs. 14%; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar.
- Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
- Infection Prevention and Control Department, The Cuban Hospital, Dukhan, Qatar.
- Department of Microbiology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar.
- Department of Medicine and Population Health Sciences, Weill Cornell Medicine, New York, NY, United States of America.
- Department of Medicine and Population Health Sciences, Weill Cornell Medicine, Education City, Qatar.
ORCID-Profile: Hanaa Nafady-Hego, Abdul-Badi Abou-Samra, Adeel A Butt
Zitieren
APA
Al Ajmi, J. A., B Malik, A., Nafady-Hego, H., Hanana, F., Abraham, J., G Garcell, H., Hudaib, G., Al-Wali, W., Eltayeb, F., Shams, S., G Thomas, A., Saleem, S., Abou-Samra, A. B., & Butt, A. A. (2024). Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar. PLOS ONE. https://doi.org/10.1371/journal.pone.0302629
Vancouver
Al Ajmi JA, B Malik A, Nafady-Hego H, Hanana F, Abraham J, G Garcell H, et al. Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar. PLOS ONE. 2024. doi:10.1371/journal.pone.0302629
BibTeX
@article{AlAjmi2024,
author = {Al Ajmi, Jameela A and B Malik, Aimon and Nafady-Hego, Hanaa and Hanana, Fathima and Abraham, Joji and G Garcell, Humberto and Hudaib, Ghada and Al-Wali, Walid and Eltayeb, Faiha and Shams, Sherin and G Thomas, Anil and Saleem, Samah and Abou-Samra, Abdul-Badi and Butt, Adeel A},
title = {Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0302629}
}
EUVIMED